BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2108949)

  • 1. Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).
    Araki A; Inoue T; Kimura S; Fukase S; Sendo F
    Jpn J Cancer Res; 1990 Jan; 81(1):69-78. PubMed ID: 2108949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators.
    Morikawa K; Kamegaya S; Yamazaki M; Mizuno D
    Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
    Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
    J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
    Morikawa K; Takeda R; Yamazaki M; Mizuno D
    Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-dependent and -independent tumoricidal activities of polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and phorbol myristate acetate in mice.
    Morikawa K; Noguchi T; Yamazaki M; Mizuno D
    Cancer Res; 1986 Jan; 46(1):66-70. PubMed ID: 3079591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cytotoxicity of polymorphonuclear leukocytes in beige mice: linkage of high responsiveness to linear beta-1,3-D-glucan with the beige gene.
    Fukase S; Inoue T; Arai S; Sendo F
    Cancer Res; 1987 Sep; 47(18):4842-7. PubMed ID: 3621179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators.
    Morikawa K; Kikuchi Y; Abe S; Yamazaki M; Mizuno D
    Gan; 1984 Apr; 75(4):370-8. PubMed ID: 6735035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
    Watabe S; Sendo F; Kimura S; Arai S
    J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of lectin and antibody-dependent polymorphonuclear leukocyte-mediated cytolysis.
    Tsunawaki S; Ikenami M; Mizuno D; Yamazaki M
    Gan; 1983 Apr; 74(2):265-72. PubMed ID: 6862147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of cytotoxic polymorphonuclear leukocytes by supernatant from a concanavalin A-stimulated spleen cell culture.
    Inoue T; Sendo F
    J Immunol; 1983 Nov; 131(5):2508-14. PubMed ID: 6605388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of polymorphonuclear leukocyte-mediated cytolysis by wheat germ agglutinin and antitumor antibody.
    Tsunawaki S; Oshima H; Mizuno D; Yamazaki M
    Gan; 1983 Apr; 74(2):258-64. PubMed ID: 6862146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-independent induction of cytocidal activity of polymorphonuclear leukocytes by phorbol myristate acetate-like tumor promoters.
    Morikawa K; Sato T; Nakazawa H; Fujita M
    Life Sci; 1986 Mar; 38(12):1073-9. PubMed ID: 3083166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of lymphokines that change the surface charge density of human polymorphonuclear leukocytes.
    Harthus HP; Hannig K
    Immunobiology; 1982; 162(2):141-52. PubMed ID: 7118152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes.
    Ikenami M; Mizuno D; Yamazaki M
    Jpn J Cancer Res; 1985 Jul; 76(7):637-43. PubMed ID: 3928561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of polymorphonuclear leukocyte-derived factor in murine tumour cell killing.
    Ikenami M; Yamazaki M
    Br J Cancer; 1985 Oct; 52(4):575-81. PubMed ID: 3840692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte-mediated cytolysis induced by animal lectin.
    Yamazaki M; Ikenami M; Komano H; Tsunawaki S; Kamiya H; Natori S; Mizuno D
    Gan; 1983 Aug; 74(4):576-83. PubMed ID: 6628907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of serum from mice treated with antitumor polysaccharide on expression of cytotoxicity by mouse peritoneal macrophages.
    Sasaki T; Tanaka M; Uchida H
    J Pharmacobiodyn; 1982 Dec; 5(12):1012-6. PubMed ID: 6763076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+/H+ exchange modulates rat neutrophil mediated tumor cytotoxicity.
    Araki A; Inoue T; Cragoe EJ; Sendo F
    Cancer Res; 1991 Jun; 51(12):3212-6. PubMed ID: 1645615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.